首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1983197

成藥市場：依產品類型、通路和地區分類

Over the Counter Drugs Market, By Product Type, By Distribution Channel, By Geography

出版日期: 2026年02月10日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，非處方成藥市場規模將達到 586.5 億美元，到 2033 年將達到 988.7 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.54%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	586.5億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2032 年）複合年成長率	8.54%	預計金額（2033 年）	988.7億美元

非處方藥（OTC）是處方箋無需醫療專業人員處方即可直接出售給消費者的藥物。這是因為藥劑師依法有權在沒有處方箋下出售這些藥物。只要按照標籤說明並在醫療專業人員的指導下使用，成藥都是安全有效的。成藥即可輕鬆治愈某些疾病。

市場動態

疾病負擔加重、對自我治療成藥）的需求不斷成長、自我用藥的趨勢日益明顯、COVID-19 大流行以及製藥公司從處方藥轉向成藥的趨勢，預計將成為預測期內推動全球成藥市場成長的主要因素。

2022年6月，Glenmark Pharmaceuticals從美國Wockhart Pharmaceuticals收購了部分已通過核准的學名藥處方成藥。該公司在聲明中表示，此次收購包括已通過核准的簡化新藥申請（ANDA），用於治療和預防胃潰瘍和腸潰瘍的法莫替丁片（10毫克和20毫克）。

2020年7月，諾華宣布了一項新計劃，旨在幫助低收入和中低收入國家的患者獲得價格合理的藥物，以治療新冠肺炎的主要症狀。在疫苗和根治性治療方法尚未問世的情況下，這顯得尤為重要。諾華的新冠肺炎產品系列包括來自山德士部門的15種學名藥成藥和非處方藥，旨在滿足低收入和中低收入國家治療新冠肺炎症狀患者的迫切需求。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本節根據以下參數，對全球成藥)市場的主要企業進行介紹：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球成藥市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球成藥)市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Pfizer Inc.
- Perrigo Company PLC
- GlaxoSmithKline PLC
- Mylan NV
- Bayer AG
- Reckitt Benckiser Group PLC
- Johnson and Johnson
- Sanofi
- Takeda Pharmaceutical Company Ltd.

第8章分析師建議

機會
分析師意見
Coherent Opportunity Map (COM)

第9章參考文獻與分析方法

參考
分析方法

簡介目錄

Product Code: CMI1218

Over The Counter Drugs Market is estimated to be valued at USD 58.65 Bn in 2026 and is expected to reach USD 98.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.54% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 58.65 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.54%	2033 Value Projection:	USD 98.87 Bn

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription (without a prescription) from the healthcare professional, as they are legally allowed to be sold by pharmacists without a prescription. When people follow the directions on the label and as directed by a health care professional, over-the-counter medicines are both safe and effective. Over-the-counter drugs treat a variety of illnesses and their symptoms and help cure some diseases simply and without the cost of seeing a doctor.

Market Dynamics

Increase in disease burden, increase in demand for OTC drugs, rising trend of self-medication, the outbreak of COVID-19, and inclination of pharma companies toward OTC drugs from RX drugs are major factors expected to drive growth of the global during the counter drugs market over the forecast period.

In June 2022, Glenmark Pharmaceuticals Ltd. acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd. in the U.S. The acquisition includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement.

In July 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries access affordable medicines to treat the major symptoms of COVID-19, a critical need in the absence of a vaccine or curative treatment. The Novartis COVID-19 portfolio includes 15 generic and OTC medicines from Sandoz division addresses urgent unmet needs of low- and lower-middle-income countries to treat patients with COVID-19 symptoms.

Key features of the study

This report provides in-depth analysis of the global over the counter drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global over the counter drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc., Perrigo Company PLC, GlaxoSmithKline PLC, Mylan NV, Bayer AG, Reckitt Benckiser Group PLC, Johnson and Johnson, Sanofi, and Takeda Pharmaceutical Company Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global over the counter drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over the counter drugs market.

Market Segmentation

By Product Type
- Cough, Cold, and Flu Products
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins
- Mineral and Supplements (VMS)
- Weight-loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Other Product Types
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Other Distribution Channels
By Regional Insights:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Perrigo Company PLC
- GlaxoSmithKline PLC
- Mylan NV
- Bayer AG
- Reckitt Benckiser Group PLC
- Johnson and Johnson
- Sanofi
- Takeda Pharmaceutical Company Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Over the Counter Drugs Market, By Product Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cough, Cold, and Flu Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Analgesics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dermatology Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Gastrointestinal Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Vitamins
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Mineral and Supplements (VMS)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Weight-loss/Dietary Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Ophthalmic Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Sleeping Aids
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Other Product Types
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Over the Counter Drugs Market, By Distribution Channel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacy
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Other Distribution Channels
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Over the Counter Drugs Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Pfizer Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Perrigo Company PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Mylan NV
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bayer AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Reckitt Benckiser Group PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson and Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sanofi
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Takeda Pharmaceutical Company Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates